 |
PDBsum entry 1xd4
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1xd4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
119:393-405
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural analysis of autoinhibition in the Ras activator Son of sevenless.
|
|
H.Sondermann,
S.M.Soisson,
S.Boykevisch,
S.S.Yang,
D.Bar-Sagi,
J.Kuriyan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The classical model for the activation of the nucleotide exchange factor Son of
sevenless (SOS) involves its recruitment to the membrane, where it engages Ras.
The recent discovery that Ras*GTP is an allosteric activator of SOS indicated
that the regulation of SOS is more complex than originally envisaged. We now
present crystallographic and biochemical analyses of a construct of SOS that
contains the Dbl homology-pleckstrin homology (DH-PH) and catalytic domains and
show that the DH-PH unit blocks the allosteric binding site for Ras and
suppresses the activity of SOS. SOS is dependent on Ras binding to the
allosteric site for both a lower level of activity, which is a result of Ras*GDP
binding, and maximal activity, which requires Ras*GTP. The action of the DH-PH
unit gates a reciprocal interaction between Ras and SOS, in which Ras converts
SOS from low to high activity forms as Ras*GDP is converted to Ras*GTP by SOS.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Structure of SOS^DH-PH-cat(A) Domain organization
of SOS and overview of a ternary Ras:SOS complex. The crystal
structure of the Ras:SOS^cat:Ras^Y64A•GppNp ternary complex is
shown (Margarit et al., 2003; PDB code 1NVV). The helical
hairpin of the Cdc25 domain is shown in orange.(B) The
crystal structure of SOS^DH-PH-cat. Two orthogonal views are
shown with coloring according to the diagram shown in (A).(C)
Comparison of SOS^DH-PH-cat with the structure of the ternary
Ras:SOS^cat:Ras•GTP complex (PDB code 1NVV). The structures
were aligned through superpositioning of the two respective Rem
domains of SOS^DH-PH-cat and SOS^cat. Ras at the catalytic site
is not shown for clarity (see [A]). Note that the distal
Ras^Y64A•GppNp (green) in the ternary complex overlaps with
the DH domain of SOS^DH-PH-cat. A close-up view of the Rem-Cdc25
interface is shown (right).
|
 |
Figure 6.
Figure 6. Activation of ERK MAP Kinase by SOSCOS1 cells
were transiently cotransfected with HA-tagged ERK2 and T7-tagged
SOS constructs as indicated. ERK2 activation was measured in
serum-starved cells by an immunoprecipitated kinase-kinase assay
using myelin basic protein (MBP) as a substrate. Results were
normalized to the vector control reaction. Western blots
detecting T7- and HA-tagged proteins are shown. (A) Activation
of ERK2 by SOS^cat and SOS^cat mutants. Results shown in the bar
diagram are from three independent experiments. Error bars
indicate standard deviations of three independent experiments.
The amout of ^32P incorporation into MBP was quantified by
phosphorimaging. Autoradiograms and Western blots shown are from
a single representative experiment. (B) Activation of ERK2 by
SOS truncations. Results shown are from a single representative
experiment. Experiments were repeated three times with similar
results.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(2004,
119,
393-405)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
R.Baker,
S.M.Lewis,
A.T.Sasaki,
E.M.Wilkerson,
J.W.Locasale,
L.C.Cantley,
B.Kuhlman,
H.G.Dohlman,
and
S.L.Campbell
(2013).
Site-specific monoubiquitination activates Ras by impeding GTPase-activating protein function.
|
| |
Nat Struct Mol Biol,
20,
46-52.
|
 |
|
|
|
|
 |
A.Fernández-Medarde,
and
E.Santos
(2011).
The RasGrf family of mammalian guanine nucleotide exchange factors.
|
| |
Biochim Biophys Acta,
1815,
170-188.
|
 |
|
|
|
|
 |
L.Gremer,
T.Merbitz-Zahradnik,
R.Dvorsky,
I.C.Cirstea,
C.P.Kratz,
M.Zenker,
A.Wittinghofer,
and
M.R.Ahmadian
(2011).
Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
|
| |
Hum Mutat,
32,
33-43.
|
 |
|
|
|
|
 |
P.D.Mace,
Y.Wallez,
M.K.Dobaczewska,
J.J.Lee,
H.Robinson,
E.B.Pasquale,
and
S.J.Riedl
(2011).
NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling.
|
| |
Nat Struct Mol Biol,
18,
1381-1387.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.K.Chakraborty,
and
A.Kosmrlj
(2010).
Statistical mechanical concepts in immunology.
|
| |
Annu Rev Phys Chem,
61,
283-303.
|
 |
|
|
|
|
 |
A.K.Chakraborty,
and
J.Das
(2010).
Pairing computation with experimentation: a powerful coupling for understanding T cell signalling.
|
| |
Nat Rev Immunol,
10,
59-71.
|
 |
|
|
|
|
 |
B.Yu,
I.R.Martins,
P.Li,
G.K.Amarasinghe,
J.Umetani,
M.E.Fernandez-Zapico,
D.D.Billadeau,
M.Machius,
D.R.Tomchick,
and
M.K.Rosen
(2010).
Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1.
|
| |
Cell,
140,
246-256.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.B.Bruning,
A.A.Parent,
G.Gil,
M.Zhao,
J.Nowak,
M.C.Pace,
C.L.Smith,
P.V.Afonine,
P.D.Adams,
J.A.Katzenellenbogen,
and
K.W.Nettles
(2010).
Coupling of receptor conformation and ligand orientation determine graded activity.
|
| |
Nat Chem Biol,
6,
837-843.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Gureasko,
O.Kuchment,
D.L.Makino,
H.Sondermann,
D.Bar-Sagi,
and
J.Kuriyan
(2010).
Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless.
|
| |
Proc Natl Acad Sci U S A,
107,
3430-3435.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.T.Groves,
and
J.Kuriyan
(2010).
Molecular mechanisms in signal transduction at the membrane.
|
| |
Nat Struct Mol Biol,
17,
659-665.
|
 |
|
|
|
|
 |
K.F.Ahmad,
and
W.A.Lim
(2010).
The minimal autoinhibited unit of the guanine nucleotide exchange factor intersectin.
|
| |
PLoS One,
5,
e11291.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.C.Jongmans,
P.M.Hoogerbrugge,
L.Hilkens,
U.Flucke,
I.van der Burgt,
K.Noordam,
M.Ruiterkamp-Versteeg,
H.G.Yntema,
W.M.Nillesen,
M.J.Ligtenberg,
A.G.van Kessel,
R.P.Kuiper,
and
N.Hoogerbrugge
(2010).
Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma.
|
| |
Genes Chromosomes Cancer,
49,
635-641.
|
 |
|
|
|
|
 |
M.T.Mazhab-Jafari,
C.B.Marshall,
M.Smith,
G.M.Gasmi-Seabrook,
V.Stambolic,
R.Rottapel,
B.G.Neel,
and
M.Ikura
(2010).
Real-time NMR study of three small GTPases reveals that fluorescent 2'(3')-O-(N-methylanthraniloyl)-tagged nucleotides alter hydrolysis and exchange kinetics.
|
| |
J Biol Chem,
285,
5132-5136.
|
 |
|
|
|
|
 |
M.Tartaglia,
and
B.D.Gelb
(2010).
Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms.
|
| |
Ann N Y Acad Sci,
1214,
99.
|
 |
|
|
|
|
 |
M.Tartaglia,
G.Zampino,
and
B.D.Gelb
(2010).
Noonan syndrome: clinical aspects and molecular pathogenesis.
|
| |
Mol Syndromol,
1,
2.
|
 |
|
|
|
|
 |
A.K.Chakraborty,
J.Das,
J.Zikherman,
M.Yang,
C.C.Govern,
M.Ho,
A.Weiss,
and
J.Roose
(2009).
Molecular origin and functional consequences of digital signaling and hysteresis during Ras activation in lymphocytes.
|
| |
Sci Signal,
2,
pt2.
|
 |
|
|
|
|
 |
A.Prasad,
J.Zikherman,
J.Das,
J.P.Roose,
A.Weiss,
and
A.K.Chakraborty
(2009).
Origin of the sharp boundary that discriminates positive and negative selection of thymocytes.
|
| |
Proc Natl Acad Sci U S A,
106,
528-533.
|
 |
|
|
|
|
 |
C.B.McDonald,
K.L.Seldeen,
B.J.Deegan,
and
A.Farooq
(2009).
SH3 domains of Grb2 adaptor bind to PXpsiPXR motifs within the Sos1 nucleotide exchange factor in a discriminate manner.
|
| |
Biochemistry,
48,
4074-4085.
|
 |
|
|
|
|
 |
E.Zhuravliova,
T.Barbakadze,
N.Narmania,
M.Sepashvili,
and
D.G.Mikeladze
(2009).
Hypoinsulinemia alleviates the GRF1/Ras/Akt anti-apoptotic pathway and induces alterations of mitochondrial ras trafficking in neuronal cells.
|
| |
Neurochem Res,
34,
1076-1082.
|
 |
|
|
|
|
 |
J.Das,
M.Ho,
J.Zikherman,
C.Govern,
M.Yang,
A.Weiss,
A.K.Chakraborty,
and
J.P.Roose
(2009).
Digital signaling and hysteresis characterize ras activation in lymphoid cells.
|
| |
Cell,
136,
337-351.
|
 |
|
|
|
|
 |
J.Das,
M.Kardar,
and
A.K.Chakraborty
(2009).
Positive feedback regulation results in spatial clustering and fast spreading of active signaling molecules on a cell membrane.
|
| |
J Chem Phys,
130,
245102.
|
 |
|
|
|
|
 |
T.S.Freedman,
H.Sondermann,
O.Kuchment,
G.D.Friedland,
T.Kortemme,
and
J.Kuriyan
(2009).
Differences in flexibility underlie functional differences in the Ras activators son of sevenless and Ras guanine nucleotide releasing factor 1.
|
| |
Structure,
17,
41-53.
|
 |
|
|
|
|
 |
A.Harding,
and
J.F.Hancock
(2008).
Ras nanoclusters: combining digital and analog signaling.
|
| |
Cell Cycle,
7,
127-134.
|
 |
|
|
|
|
 |
C.Sampaio,
M.Dance,
A.Montagner,
T.Edouard,
N.Malet,
B.Perret,
A.Yart,
J.P.Salles,
and
P.Raynal
(2008).
Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition.
|
| |
Mol Cell Biol,
28,
587-600.
|
 |
|
|
|
|
 |
G.M.Findlay,
and
T.Pawson
(2008).
How is SOS activated? Let us count the ways.
|
| |
Nat Struct Mol Biol,
15,
538-540.
|
 |
|
|
|
|
 |
J.Gureasko,
W.J.Galush,
S.Boykevisch,
H.Sondermann,
D.Bar-Sagi,
J.T.Groves,
and
J.Kuriyan
(2008).
Membrane-dependent signal integration by the Ras activator Son of sevenless.
|
| |
Nat Struct Mol Biol,
15,
452-461.
|
 |
|
|
|
|
 |
K.D.Swanson,
J.M.Winter,
M.Reis,
M.Bentires-Alj,
H.Greulich,
R.Grewal,
R.H.Hruban,
C.J.Yeo,
Y.Yassin,
O.Iartchouk,
K.Montgomery,
S.P.Whitman,
M.A.Caligiuri,
M.L.Loh,
D.G.Gilliland,
A.T.Look,
R.Kucherlapati,
S.E.Kern,
M.Meyerson,
and
B.G.Neel
(2008).
SOS1 mutations are rare in human malignancies: Implications for Noonan syndrome patients.
|
| |
Genes Chromosomes Cancer,
47,
253-259.
|
 |
|
|
|
|
 |
K.D.Swanson,
Y.Tang,
D.F.Ceccarelli,
F.Poy,
J.P.Sliwa,
B.G.Neel,
and
M.J.Eck
(2008).
The Skap-hom dimerization and PH domains comprise a 3'-phosphoinositide-gated molecular switch.
|
| |
Mol Cell,
32,
564-575.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Buday,
and
J.Downward
(2008).
Many faces of Ras activation.
|
| |
Biochim Biophys Acta,
1786,
178-187.
|
 |
|
|
|
|
 |
R.Tanizaki,
A.Katsumi,
H.Kiyoi,
S.Kunishima,
T.Iwasaki,
Y.Ishikawa,
M.Kobayashi,
A.Abe,
T.Matsushita,
T.Watanabe,
T.Kojima,
K.Kaibuchi,
S.Kojima,
and
T.Naoe
(2008).
Mutational analysis of SOS1 gene in acute myeloid leukemia.
|
| |
Int J Hematol,
88,
460-462.
|
 |
|
|
|
|
 |
Y.Narumi,
Y.Aoki,
T.Niihori,
M.Sakurai,
H.Cavé,
A.Verloes,
K.Nishio,
H.Ohashi,
K.Kurosawa,
N.Okamoto,
H.Kawame,
S.Mizuno,
T.Kondoh,
M.C.Addor,
A.Coeslier-Dieux,
C.Vincent-Delorme,
K.Tabayashi,
M.Aoki,
T.Kobayashi,
A.Guliyeva,
S.Kure,
and
Y.Matsubara
(2008).
Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome.
|
| |
J Hum Genet,
53,
834-841.
|
 |
|
|
|
|
 |
A.Delprato,
and
D.G.Lambright
(2007).
Structural basis for Rab GTPase activation by VPS9 domain exchange factors.
|
| |
Nat Struct Mol Biol,
14,
406-412.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.E.Roberts,
T.Araki,
K.D.Swanson,
K.T.Montgomery,
T.A.Schiripo,
V.A.Joshi,
L.Li,
Y.Yassin,
A.M.Tamburino,
B.G.Neel,
and
R.S.Kucherlapati
(2007).
Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
|
| |
Nat Genet,
39,
70-74.
|
 |
|
|
|
|
 |
J.L.Bos,
H.Rehmann,
and
A.Wittinghofer
(2007).
GEFs and GAPs: critical elements in the control of small G proteins.
|
| |
Cell,
129,
865-877.
|
 |
|
|
|
|
 |
J.P.DiNitto,
A.Delprato,
M.T.Gabe Lee,
T.C.Cronin,
S.Huang,
A.Guilherme,
M.P.Czech,
and
D.G.Lambright
(2007).
Structural basis and mechanism of autoregulation in 3-phosphoinositide-dependent Grp1 family Arf GTPase exchange factors.
|
| |
Mol Cell,
28,
569-583.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.P.Roose,
M.Mollenauer,
M.Ho,
T.Kurosaki,
and
A.Weiss
(2007).
Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes.
|
| |
Mol Cell Biol,
27,
2732-2745.
|
 |
|
|
|
|
 |
K.Modzelewska,
M.G.Elgort,
J.Huang,
G.Jongeward,
A.Lauritzen,
C.H.Yoon,
P.W.Sternberg,
and
N.Moghal
(2007).
An activating mutation in sos-1 identifies its Dbl domain as a critical inhibitor of the epidermal growth factor receptor pathway during Caenorhabditis elegans vulval development.
|
| |
Mol Cell Biol,
27,
3695-3707.
|
 |
|
|
|
|
 |
M.K.Chhatriwala,
L.Betts,
D.K.Worthylake,
and
J.Sondek
(2007).
The DH and PH domains of Trio coordinately engage Rho GTPases for their efficient activation.
|
| |
J Mol Biol,
368,
1307-1320.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.M.McKay,
and
D.K.Morrison
(2007).
Integrating signals from RTKs to ERK/MAPK.
|
| |
Oncogene,
26,
3113-3121.
|
 |
|
|
|
|
 |
M.Tartaglia,
L.A.Pennacchio,
C.Zhao,
K.K.Yadav,
V.Fodale,
A.Sarkozy,
B.Pandit,
K.Oishi,
S.Martinelli,
W.Schackwitz,
A.Ustaszewska,
J.Martin,
J.Bristow,
C.Carta,
F.Lepri,
C.Neri,
I.Vasta,
K.Gibson,
C.J.Curry,
J.P.Siguero,
M.C.Digilio,
G.Zampino,
B.Dallapiccola,
D.Bar-Sagi,
and
B.D.Gelb
(2007).
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.
|
| |
Nat Genet,
39,
75-79.
|
 |
|
|
|
|
 |
M.Zenker,
D.Horn,
D.Wieczorek,
J.Allanson,
S.Pauli,
I.van der Burgt,
H.G.Doerr,
H.Gaspar,
M.Hofbeck,
G.Gillessen-Kaesbach,
A.Koch,
P.Meinecke,
S.Mundlos,
A.Nowka,
A.Rauch,
S.Reif,
C.von Schnakenburg,
H.Seidel,
L.E.Wehner,
C.Zweier,
S.Bauhuber,
V.Matejas,
C.P.Kratz,
C.Thomas,
and
K.Kutsche
(2007).
SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome.
|
| |
J Med Genet,
44,
651-656.
|
 |
|
|
|
|
 |
S.Schubbert,
K.Shannon,
and
G.Bollag
(2007).
Hyperactive Ras in developmental disorders and cancer.
|
| |
Nat Rev Cancer,
7,
295-308.
|
 |
|
|
|
|
 |
A.Wittinghofer
(2006).
Phosphoryl transfer in Ras proteins, conclusive or elusive?
|
| |
Trends Biochem Sci,
31,
20-23.
|
 |
|
|
|
|
 |
B.Ford,
V.Hornak,
H.Kleinman,
and
N.Nassar
(2006).
Structure of a transient intermediate for GTP hydrolysis by ras.
|
| |
Structure,
14,
427-436.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.C.Houtman,
H.Yamaguchi,
M.Barda-Saad,
A.Braiman,
B.Bowden,
E.Appella,
P.Schuck,
and
L.E.Samelson
(2006).
Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1.
|
| |
Nat Struct Mol Biol,
13,
798-805.
|
 |
|
|
|
|
 |
S.Boykevisch,
C.Zhao,
H.Sondermann,
P.Philippidou,
S.Halegoua,
J.Kuriyan,
and
D.Bar-Sagi
(2006).
Regulation of ras signaling dynamics by Sos-mediated positive feedback.
|
| |
Curr Biol,
16,
2173-2179.
|
 |
|
|
|
|
 |
T.S.Freedman,
H.Sondermann,
G.D.Friedland,
T.Kortemme,
D.Bar-Sagi,
S.Marqusee,
and
J.Kuriyan
(2006).
A Ras-induced conformational switch in the Ras activator Son of sevenless.
|
| |
Proc Natl Acad Sci U S A,
103,
16692-16697.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Harding,
T.Tian,
E.Westbury,
E.Frische,
and
J.F.Hancock
(2005).
Subcellular localization determines MAP kinase signal output.
|
| |
Curr Biol,
15,
869-873.
|
 |
|
|
|
|
 |
B.B.Friday,
and
A.A.Adjei
(2005).
K-ras as a target for cancer therapy.
|
| |
Biochim Biophys Acta,
1756,
127-144.
|
 |
|
|
|
|
 |
H.Sondermann,
B.Nagar,
D.Bar-Sagi,
and
J.Kuriyan
(2005).
Computational docking and solution x-ray scattering predict a membrane-interacting role for the histone domain of the Ras activator son of sevenless.
|
| |
Proc Natl Acad Sci U S A,
102,
16632-16637.
|
 |
|
|
|
|
 |
K.L.Rossman,
C.J.Der,
and
J.Sondek
(2005).
GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors.
|
| |
Nat Rev Mol Cell Biol,
6,
167-180.
|
 |
|
|
|
|
 |
K.L.Rossman,
and
J.Sondek
(2005).
Larger than Dbl: new structural insights into RhoA activation.
|
| |
Trends Biochem Sci,
30,
163-165.
|
 |
|
|
|
|
 |
N.Mitin,
K.L.Rossman,
and
C.J.Der
(2005).
Signaling interplay in Ras superfamily function.
|
| |
Curr Biol,
15,
R563-R574.
|
 |
|
|
|
|
 |
S.Pasqualato,
and
J.Cherfils
(2005).
Crystallographic evidence for substrate-assisted GTP hydrolysis by a small GTP binding protein.
|
| |
Structure,
13,
533-540.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |